BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 20133021)

  • 1. Modulation of doxorubicin activity in cancer cells by conjugation with fatty acyl and terpenyl hydrazones.
    Effenberger K; Breyer S; Schobert R
    Eur J Med Chem; 2010 May; 45(5):1947-54. PubMed ID: 20133021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modification of uptake and subcellular distribution of doxorubicin by N-acylhydrazone residues as visualised by intrinsic fluorescence.
    Effenberger-Neidnicht K; Breyer S; Mahal K; Sasse F; Schobert R
    Cancer Chemother Pharmacol; 2012 Jan; 69(1):85-90. PubMed ID: 21607555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatty acyl amide derivatives of doxorubicin: synthesis and in vitro anticancer activities.
    Chhikara BS; St Jean N; Mandal D; Kumar A; Parang K
    Eur J Med Chem; 2011 Jun; 46(6):2037-42. PubMed ID: 21420207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of thiobenzanilides as anticancer agents.
    Hu WP; Yu HS; Chen YR; Tsai YM; Chen YK; Liao CC; Chang LS; Wang JJ
    Bioorg Med Chem; 2008 May; 16(9):5295-302. PubMed ID: 18359635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, structure-activity relationships, and antitumor studies of 2-benzoxazolyl hydrazones derived from alpha-(N)-acyl heteroaromatics.
    Easmon J; Pürstinger G; Thies KS; Heinisch G; Hofmann J
    J Med Chem; 2006 Oct; 49(21):6343-50. PubMed ID: 17034140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of thymoquinone-fatty acid conjugates on cancer cells.
    Breyer S; Effenberger K; Schobert R
    ChemMedChem; 2009 May; 4(5):761-8. PubMed ID: 19322799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New class of potent antitumor acylhydrazone derivatives containing furan.
    Cui Z; Li Y; Ling Y; Huang J; Cui J; Wang R; Yang X
    Eur J Med Chem; 2010 Dec; 45(12):5576-84. PubMed ID: 20884091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An essential oil and its major constituent isointermedeol induce apoptosis by increased expression of mitochondrial cytochrome c and apical death receptors in human leukaemia HL-60 cells.
    Kumar A; Malik F; Bhushan S; Sethi VK; Shahi AK; Kaur J; Taneja SC; Qazi GN; Singh J
    Chem Biol Interact; 2008 Feb; 171(3):332-47. PubMed ID: 18070620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasmall gold-doxorubicin conjugates rapidly kill apoptosis-resistant cancer cells.
    Zhang X; Chibli H; Mielke R; Nadeau J
    Bioconjug Chem; 2011 Feb; 22(2):235-43. PubMed ID: 21189001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor effects of curcumin, alone or in combination with cisplatin or doxorubicin, on human hepatic cancer cells. Analysis of their possible relationship to changes in NF-kB activation levels and in IAP gene expression.
    Notarbartolo M; Poma P; Perri D; Dusonchet L; Cervello M; D'Alessandro N
    Cancer Lett; 2005 Jun; 224(1):53-65. PubMed ID: 15911101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18beta-Glycyrrhetinic acid induces apoptotic cell death in SiHa cells and exhibits a synergistic effect against antibiotic anti-cancer drug toxicity.
    Lee CS; Kim YJ; Lee MS; Han ES; Lee SJ
    Life Sci; 2008 Sep; 83(13-14):481-9. PubMed ID: 18721818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythropoietin fails to interfere with the antiproliferative and cytotoxic effects of antitumor drugs.
    Gewirtz DA; Di X; Walker TD; Sawyer ST
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2232-8. PubMed ID: 16609039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteinase-3, a serine protease which mediates doxorubicin-induced apoptosis in the HL-60 leukemia cell line, is downregulated in its doxorubicin-resistant variant.
    Wu CH; Gordon J; Rastegar M; Ogretmen B; Safa AR
    Oncogene; 2002 Aug; 21(33):5160-74. PubMed ID: 12140766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1,25-Dihydroxyvitamin D3 enhances the susceptibility of breast cancer cells to doxorubicin-induced oxidative damage.
    Ravid A; Rocker D; Machlenkin A; Rotem C; Hochman A; Kessler-Icekson G; Liberman UA; Koren R
    Cancer Res; 1999 Feb; 59(4):862-7. PubMed ID: 10029076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptosis-inducing active components from Corbicula fluminea through activation of caspase-2 and production of reactive oxygen species in human leukemia HL-60 cells.
    Huang YT; Huang YH; Hour TC; Pan BS; Liu YC; Pan MH
    Food Chem Toxicol; 2006 Aug; 44(8):1261-72. PubMed ID: 16545898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of some nitrogen containing steroidal heterocycles.
    Abdelhalim MM; Kamel EM; Rabie ST; Mohamed NR
    Steroids; 2011 Jan; 76(1-2):78-84. PubMed ID: 20849869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of induction of apoptosis by anthraquinone anticancer drugs aclarubicin and mitoxantrone in comparison with doxorubicin: relation to drug cytotoxicity and caspase-3 activation.
    Koceva-Chyła A; Jedrzejczak M; Skierski J; Kania K; Jóźwiak Z
    Apoptosis; 2005 Dec; 10(6):1497-514. PubMed ID: 16215684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitivity of K562 and HL-60 cells to edelfosine, an ether lipid drug, correlates with production of reactive oxygen species.
    Wagner BA; Buettner GR; Oberley LW; Burns CP
    Cancer Res; 1998 Jul; 58(13):2809-16. PubMed ID: 9661895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (Arene)Cl₂Ru(II) complexes with N-coordinated estrogen and androgen isonicotinates: interaction with sex hormone binding globulin and anticancer activity.
    Schobert R; Seibt S; Effenberger-Neidnicht K; Underhill C; Biersack B; Hammond GL
    Steroids; 2011 Mar; 76(4):393-9. PubMed ID: 21184767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HPMA copolymers containing doxorubicin bound by a proteolytically or hydrolytically cleavable bond: comparison of biological properties in vitro.
    Kovár M; Kovár L; Subr V; Etrych T; Ulbrich K; Mrkvan T; Loucká J; Ríhová B
    J Control Release; 2004 Sep; 99(2):301-14. PubMed ID: 15380639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.